File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Recent progress on anticancer candidates in patents of herbal medicinal products
  • Basic View
  • Metadata View
  • XML View
TitleRecent progress on anticancer candidates in patents of herbal medicinal products
 
AuthorsFeng, Y2
Wang, N1
Zhu, M1
Feng, Y
Li, H2
Tsao, S1
 
KeywordsAnticancer drugs
Antimetastasis drugs
Chinese medicines
Complementary and alternative medicines
Herbal medicine
Patent
 
Issue Date2011
 
PublisherBentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/pfna/index.htm
 
CitationRecent Patents On Food, Nutrition And Agriculture, 2011, v. 3 n. 1, p. 30-48 [How to Cite?]
DOI: http://dx.doi.org/10.2174/1876142911103010030
 
AbstractHerbal medicines in treatment of cancer as complementary and alternative therapy are accepted increasingly with growing scientific evidences of biomedical research and clinical trials. Anticancer drugs discovered from herbal medicines have a long history and some of them have been used in clinical setting as the conventional anticancer drugs. Actually, herbal medicines are a source for anticancer drug discovery and drug development. Recently, research continuously focuses on clues from traditional use of herbal medicines to develop new anticancer drugs in single pure compounds. On the other hand, standardized various extracts or fractions with anticancer effects or with adjuvant therapy in cancer treatment coming from single or mixed herbs are also accepted forms as dietary supplements and botanical drug products in the US for current statutory regulations. In the present paper, we analyzed the patented agents in the US from herbal medicines in recent ten years, both as potential anticancer extracts/fractions (containing multi-components) and single pure compound(s) that act as new anticancer substances. This review also highlighted the advances in knowledge about quality control, safety, efficacy and recent progress in anticancer candidates in patents of botanical drug products from herbal medicines. © 2011 Bentham Science Publishers Ltd.
 
ISSN2212-7984
 
DOIhttp://dx.doi.org/10.2174/1876142911103010030
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorFeng, Y
 
dc.contributor.authorWang, N
 
dc.contributor.authorZhu, M
 
dc.contributor.authorFeng, Y
 
dc.contributor.authorLi, H
 
dc.contributor.authorTsao, S
 
dc.date.accessioned2011-08-26T14:41:19Z
 
dc.date.available2011-08-26T14:41:19Z
 
dc.date.issued2011
 
dc.description.abstractHerbal medicines in treatment of cancer as complementary and alternative therapy are accepted increasingly with growing scientific evidences of biomedical research and clinical trials. Anticancer drugs discovered from herbal medicines have a long history and some of them have been used in clinical setting as the conventional anticancer drugs. Actually, herbal medicines are a source for anticancer drug discovery and drug development. Recently, research continuously focuses on clues from traditional use of herbal medicines to develop new anticancer drugs in single pure compounds. On the other hand, standardized various extracts or fractions with anticancer effects or with adjuvant therapy in cancer treatment coming from single or mixed herbs are also accepted forms as dietary supplements and botanical drug products in the US for current statutory regulations. In the present paper, we analyzed the patented agents in the US from herbal medicines in recent ten years, both as potential anticancer extracts/fractions (containing multi-components) and single pure compound(s) that act as new anticancer substances. This review also highlighted the advances in knowledge about quality control, safety, efficacy and recent progress in anticancer candidates in patents of botanical drug products from herbal medicines. © 2011 Bentham Science Publishers Ltd.
 
dc.description.naturepostprint
 
dc.identifier.citationRecent Patents On Food, Nutrition And Agriculture, 2011, v. 3 n. 1, p. 30-48 [How to Cite?]
DOI: http://dx.doi.org/10.2174/1876142911103010030
 
dc.identifier.doihttp://dx.doi.org/10.2174/1876142911103010030
 
dc.identifier.epage48
 
dc.identifier.hkuros191220
 
dc.identifier.hkuros226726
 
dc.identifier.issn2212-7984
 
dc.identifier.issue1
 
dc.identifier.openurl
 
dc.identifier.pmid21114469
 
dc.identifier.scopuseid_2-s2.0-79955007154
 
dc.identifier.spage30
 
dc.identifier.urihttp://hdl.handle.net/10722/138137
 
dc.identifier.volume3
 
dc.languageeng
 
dc.publisherBentham Science Publishers Ltd. The Journal's web site is located at http://www.bentham.org/pfna/index.htm
 
dc.publisher.placeNetherlands
 
dc.relation.ispartofRecent Patents on Food, Nutrition and Agriculture
 
dc.relation.referencesReferences in Scopus
 
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
 
dc.subject.meshAntineoplastic Agents, Phytogenic - adverse effects - therapeutic use
 
dc.subject.meshDrug Discovery
 
dc.subject.meshNeoplasms - drug therapy
 
dc.subject.meshPhytotherapy
 
dc.subject.meshPlant Extracts - adverse effects - therapeutic use
 
dc.subjectAnticancer drugs
 
dc.subjectAntimetastasis drugs
 
dc.subjectChinese medicines
 
dc.subjectComplementary and alternative medicines
 
dc.subjectHerbal medicine
 
dc.subjectPatent
 
dc.titleRecent progress on anticancer candidates in patents of herbal medicinal products
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Feng, Y</contributor.author>
<contributor.author>Wang, N</contributor.author>
<contributor.author>Zhu, M</contributor.author>
<contributor.author>Feng, Y</contributor.author>
<contributor.author>Li, H</contributor.author>
<contributor.author>Tsao, S</contributor.author>
<date.accessioned>2011-08-26T14:41:19Z</date.accessioned>
<date.available>2011-08-26T14:41:19Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>Recent Patents On Food, Nutrition And Agriculture, 2011, v. 3 n. 1, p. 30-48</identifier.citation>
<identifier.issn>2212-7984</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/138137</identifier.uri>
<description.abstract>Herbal medicines in treatment of cancer as complementary and alternative therapy are accepted increasingly with growing scientific evidences of biomedical research and clinical trials. Anticancer drugs discovered from herbal medicines have a long history and some of them have been used in clinical setting as the conventional anticancer drugs. Actually, herbal medicines are a source for anticancer drug discovery and drug development. Recently, research continuously focuses on clues from traditional use of herbal medicines to develop new anticancer drugs in single pure compounds. On the other hand, standardized various extracts or fractions with anticancer effects or with adjuvant therapy in cancer treatment coming from single or mixed herbs are also accepted forms as dietary supplements and botanical drug products in the US for current statutory regulations. In the present paper, we analyzed the patented agents in the US from herbal medicines in recent ten years, both as potential anticancer extracts/fractions (containing multi-components) and single pure compound(s) that act as new anticancer substances. This review also highlighted the advances in knowledge about quality control, safety, efficacy and recent progress in anticancer candidates in patents of botanical drug products from herbal medicines. &#169; 2011 Bentham Science Publishers Ltd.</description.abstract>
<language>eng</language>
<publisher>Bentham Science Publishers Ltd. The Journal&apos;s web site is located at http://www.bentham.org/pfna/index.htm</publisher>
<relation.ispartof>Recent Patents on Food, Nutrition and Agriculture</relation.ispartof>
<rights>Creative Commons: Attribution 3.0 Hong Kong License</rights>
<subject>Anticancer drugs</subject>
<subject>Antimetastasis drugs</subject>
<subject>Chinese medicines</subject>
<subject>Complementary and alternative medicines</subject>
<subject>Herbal medicine</subject>
<subject>Patent</subject>
<subject.mesh>Antineoplastic Agents, Phytogenic - adverse effects - therapeutic use</subject.mesh>
<subject.mesh>Drug Discovery</subject.mesh>
<subject.mesh>Neoplasms - drug therapy</subject.mesh>
<subject.mesh>Phytotherapy</subject.mesh>
<subject.mesh>Plant Extracts - adverse effects - therapeutic use</subject.mesh>
<title>Recent progress on anticancer candidates in patents of herbal medicinal products</title>
<type>Article</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=1876-1429&amp;volume=3&amp;issue=1&amp;spage=30&amp;epage=48&amp;date=2011&amp;atitle=Recent+progress+on+anticancer+candidates+in+patents+of+herbal+medicinal+products</identifier.openurl>
<description.nature>postprint</description.nature>
<identifier.doi>10.2174/1876142911103010030</identifier.doi>
<identifier.pmid>21114469</identifier.pmid>
<identifier.scopus>eid_2-s2.0-79955007154</identifier.scopus>
<identifier.hkuros>191220</identifier.hkuros>
<identifier.hkuros>226726</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-79955007154&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>3</identifier.volume>
<identifier.issue>1</identifier.issue>
<identifier.spage>30</identifier.spage>
<identifier.epage>48</identifier.epage>
<publisher.place>Netherlands</publisher.place>
<bitstream.url>http://hub.hku.hk/bitstream/10722/138137/1/Content.pdf</bitstream.url>
</item>
Author Affiliations
  1. The University of Hong Kong
  2. Sun Yat-Sen University